1. 5-HT6 receptor agonist and antagonist improve memory impairments and hippocampal BDNF signaling alterations induced by MK-801
   Joanna Rychtyk et al, 2019, Brain Research CrossRef
2. Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
   Zhi-min Yu et al, 2019, Frontiers in Psychiatry CrossRef
3. Icariin sustains the proliferation and differentiation of Aβ25-35-treated hippocampal neural stem cells via the BDNF-TrkB-ERK/Akt signaling pathway
   Quan Lu et al, 2020, Neurological Research CrossRef
4. Increased behavioral and neuronal responses to a hallucinogenic drug after adolescent toluene exposure in mice: Effects of antipsychotic treatment
   Mei-Yi Lee et al, 2020, Toxicology CrossRef
5. Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats
   Tarek M. Ibrahim et al, 2021, Journal of Drug Delivery Science and Technology CrossRef
6. Advantages and Limitations of Animal Schizophrenia Models
   Magdalena Białoń et al, 2022, International Journal of Molecular Sciences CrossRef
7. Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
   Andrea de Bartolomeis et al, 2022, Pharmacological Research CrossRef
8. Risperidone Reverses the Downregulation of BDNF in Hippocampal Neurons and MK801-Induced Cognitive Impairment in Rats
   Wenjuan Yu et al, 2019, Frontiers in Behavioral Neuroscience CrossRef
9. Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus
   Ankit Uniyal et al, 2019, Pharmacology Biochemistry and Behavior CrossRef